Please provide your email address to receive an email when new articles are posted on . Primary care providers frequently order prostate cancer screenings for older patients, even when they provide ...

Last week, Joe Biden was diagnosed with an "aggressive" form of prostate cancer — one that has metastasized to his bones. The discovery of a prostate nodule was made after he sought medical care for ...

Prostate cancer remains the most common malignancy among U.S. men, and internationally it ranks fourth. Though few studies have offered much insight into what triggers this disease, a growing number ...

Current guidelines recommend against screening for prostate cancer in men who are 70 years old and older, as it is considered to be 'low value' with little or no benefit for the individual. Yet a new ...

A new study by researchers at the Johns Hopkins University has found that second opinions did not change treatment choice among men diagnosed with low-risk prostate cancer. Men often seek second ...

Prostate specific antigen dynamics and prostate cancer risk: A population-based study. Overall risk of a PSA test, compared to men aged 55-69, stratified by age group. This is an ASCO Meeting Abstract ...

Prostate cancer is a common cancer in men that, once it progresses to the later stages, has serious morbidity and mortality consequences as well as burdensome financial issues for patients, the ...

At a minimum, the value framework assessment reminds us that there is considerable cost to both patients and society for more effective treatment. Oncologists should include cost in the overall ...

Prostate cancer is the second-leading cause of cancer death in men with more than 34,000 deaths in the U.S. each year, according to the American Cancer Society. But guidelines for prostate cancer ...

WASHINGTON (Reuters) - A new analysis of data from a key prostate cancer study has strengthened the view that a drug that is now sold as a generic may be a valuable weapon to prevent prostate cancer, ...